As chronic inflammation underlies diabetes, neuro-degeneration, cardiovascular failure and even cancer, the limits of small-molecule anti-inflammatories become ever clearer. Now researchers from Naval Medical University & Shanghai University, led by Prof. Yu Chen, Prof. Jishun Yang and Prof. Meiqi Chang, have delivered a 55-page roadmap on “smart” nanomedicines that scavenge ROS, re-programme immunity and restore tissue homeostasis. The work, published in Nano-Micro Letters , outlines design rules, AI-assisted screening and scalable synthesis that could fast-track next-generation anti-inflammatory therapeutics.
Why Advanced Nanomedicines Matter
Innovative Design and Features
Applications and Future Outlook
This comprehensive review provides a blueprint linking material innovation, computational design and multi-organ disease biology to create safe, potent and cost-effective anti-inflammatory nanotherapies.
Stay tuned for more breakthroughs from Professor Chen’s and Professor Yang’s teams at Shanghai University and Naval Medical Center!
Nano-Micro Letters
Experimental study
Advanced Nanomedicines for Treating Refractory Inflammation‑Related Diseases
7-Jul-2025